Accuray Fiscal Q1 2027 Earnings: Service Growth Could Not Offset Product Weakness

Accuray (NASDAQ: ARAY) reported fiscal Q1 2027 revenue of $86.5 million, down 8% from $93.9 million a year earlier, while diluted GAAP EPS was $0.07 versus a loss of $0.18. For the quarter ended September 30, 2026, service growth and lower underlying expenses helped adjusted EBITDA turn positive, but product revenue, orders, and backlog weakened. GAAP profit was heavily affected by a $59.6 million non-cash debt-extinguishment gain and a $35.4 million non-cash goodwill impairment charge.

Key Financial Results

The revenue decline was driven by products, while higher service revenue limited the overall contraction. Gross profit fell by about 3%, less than revenue, as service pricing and lower service labor costs helped lift total gross margin by 130 basis points to 30.1%.

Operating expenses were $62.6 million on a GAAP basis because of the goodwill impairment. Excluding that charge, operating expenses declined 29% to $27.2 million, contributing to positive adjusted EBITDA despite lower revenue.

The exclusion-based net loss removes only the debt-extinguishment gain and goodwill impairment identified by Accuray. Adjusted EBITDA excludes additional items under the company’s non-GAAP definition.

Product Weakness Offset Service Progress

Service revenue increased as pricing actions and nearly 3% growth in Accuray’s global installed base supported the business. Service gross margin reached 35.1%, up 120 basis points, reflecting both pricing and a lower service labor cost structure.

Product performance moved in the opposite direction. Revenue fell 26%, while gross orders were approximately half the prior-year level and the book-to-bill ratio dropped below 1.0.

Accuray defines book-to-bill as gross orders divided by product revenue. The combination of a 0.7 ratio, negative net orders, and a smaller backlog indicates that improved service performance has not yet translated into stronger product demand.

Cost Cuts Lift Underlying Earnings While Orders Weaken

Accuray said its transformation initiatives delivered approximately $13 million of year-over-year cost and margin improvement. The measures included headcount reductions, more efficient use of strategic partners, narrower product development and marketing plans, and tighter discretionary spending.

Expenses declined across the main operating categories before the impairment charge. Research and development expense fell to $7.8 million from $11.2 million, selling and marketing declined to $8.7 million from $11.7 million, and general and administrative expense decreased to $10.3 million from $12.6 million. Restructuring charges also fell to $0.4 million from $2.8 million.

That operating discipline allowed adjusted EBITDA to turn positive even as revenue declined. However, the company still recorded a $14.0 million loss after excluding the two major non-cash accounting items, leaving product orders and revenue recovery as the main test of whether the improved cost structure can produce sustained profitability.

GAAP Profit Was Driven by Debt Accounting

The $59.6 million debt-extinguishment gain was the primary reason Accuray reported GAAP net income despite a $36.5 million operating loss. The gain resulted from extinguishment accounting after a contingent conversion feature was added to the term loans and the replacement loans were initially recognized at fair value. Its recognition did not depend on completing the proposed debt-for-equity exchange.

The $35.4 million goodwill impairment moved in the opposite direction, increasing GAAP operating expenses without using cash. These two items make GAAP net income less representative of the quarter’s underlying operating result. Interest expense also increased to $11.8 million from $8.1 million, remaining a meaningful burden below the operating line.

Liquidity and Financing

Cash, cash equivalents, and restricted cash totaled $50.4 million at quarter-end, up $1.6 million from June 30, 2026. The company also received a $15 million investment through its July financing transaction with TCW.

After quarter-end, shareholders approved proposals needed to help enable a planned exchange of $40 million in term-loan debt for convertible preferred equity. Accuray said the financing actions are intended to reduce leverage, improve liquidity, and provide greater strategic flexibility, although the results did not present the exchange as completed during the reported quarter.

Management Commentary

CEO Steve La Neve characterized fiscal 2027 as a year focused on execution after the company’s fiscal 2026 transformation. Management’s immediate commercial priority is converting customer engagement into stronger product orders and revenue while maintaining the cost controls and service-margin improvements already achieved.

Accuray also signed an agreement with RaySearch to advance online adaptive radiation therapy and expanded its work with Samsung NeuroLogica on volumetric imaging for the CyberKnife System. The company did not quantify the expected financial contribution from these collaborations.

Risks Investors Need to Watch

• Product and order recovery: Product revenue declined 26%, gross orders fell by about half, and backlog was approximately 31% lower. Continued weakness could limit future system revenue even if service revenue continues to grow.
• Underlying losses and interest expense: Adjusted EBITDA was positive, but the company remained loss-making after excluding the major non-cash items. Interest expense rose to $11.8 million, increasing the earnings burden associated with its debt.
• Financing execution: Shareholder approval advanced the proposed debt-for-equity exchange, but completing the transaction and realizing the intended leverage and liquidity benefits remain important balance-sheet considerations.

Summary

Accuray’s fiscal Q1 2027 results showed meaningful progress in service margins and cost control, allowing adjusted EBITDA to turn positive despite lower revenue. That improvement was overshadowed by weak product sales, sharply lower orders, and a smaller backlog, while reported GAAP profit largely reflected non-cash debt accounting. The next operating test is whether Accuray can pair its leaner cost structure with improved product orders and revenue conversion.